| Jun 16 2025 |
FDA Reimagined: Faster, Friendlier, and Focused on Cures |
Katten |
| Jun 16 2025 |
FDA Releases Educational Materials on the NDIN Process |
Keller and Heckman LLP |
| Jun 16 2025 |
FDA Reportedly Set to Define UPFs |
Keller and Heckman LLP |
| Jun 13 2025 |
FTC and DOJ Announce Listening Sessions on Lowering American’s Drug Prices |
Katten |
| Jun 13 2025 |
Defra Calls for Comments on Indicative Lists for LC-PFCAs, Their Salts, and Related Compounds |
Bergeson & Campbell, P.C. |
| Jun 13 2025 |
Justice Rushed Is Justice Denied: Why Alabama’s Attorney General Can Show Wisdom Rather Than Power on Hemp |
Bradley Arant Boult Cummings LLP |
| Jun 12 2025 |
FDA Ratchets Enforcement on Social Media Promotion in New Warning Letter |
Sheppard, Mullin, Richter & Hampton LLP |
| Jun 11 2025 |
HHS Announces Release of MAHA Report |
Bergeson & Campbell, P.C. |
| Jun 11 2025 |
It’s Not an Emergency: U.S. Court of International Trade Declares IEEPA Tariff Actions as Unlawful |
Barnes & Thornburg LLP |
| Jun 11 2025 |
Cloud Control: Alabama’s Newest Nicotine Regulation That’s Just Too “Juicy” to Ignore |
Bradley Arant Boult Cummings LLP |
| Jun 11 2025 |
Oregon’s Cannabis Labor Peace Law Struck Down |
Proskauer Rose LLP |
| Jun 10 2025 |
Chobani “Zero Sugar” Lawsuit Dismissed Due to Federal Preemption |
Keller and Heckman LLP |
| Jun 10 2025 |
What to Watch: FDA Shifts Attention on Artificial Intelligence |
Sheppard, Mullin, Richter & Hampton LLP |
| Jun 10 2025 |
California’s E-Waste EPR Program Continues to Exclude E-Cigarettes |
Keller and Heckman LLP |
| Jun 10 2025 |
Decree for the Promotion of Pharmaceutical Investment and the So-Called “Plant Requirement” |
OLIVARES |
| Jun 10 2025 |
Color Me Bad: The Push to Remove Color Additives from Food [Podcast] |
Keller and Heckman LLP |
| Jun 10 2025 |
Health Law Diagnosed: PBM Update Spring 2025 [Podcast] |
Mintz |
| Jun 10 2025 |
Alabama Cannabis Court Faces Dilemma: To Treat Applicants Fairly or Equally? |
Bradley Arant Boult Cummings LLP |
| Jun 10 2025 |
False Claims Act Enforcement of Pharmacy Pricing & Prescribing Practices: The Walgreens Cases |
Robinson & Cole LLP |
| Jun 9 2025 |
Healthcare Preview for the Week of: June 9, 2025 [Podcast] |
McDermott Will & Schulte LLP |
| Jun 9 2025 |
PBMs Sue Arkansas Over Restrictive PBM Ownership Law |
Mintz |
| Jun 7 2025 |
California Bill Would Ban Ultra-Processed Foods in Schools |
Keller and Heckman LLP |
| Jun 7 2025 |
FDA Lessens Hurdles for Color Additive Changes in Drugs |
Keller and Heckman LLP |
| Jun 6 2025 |
Call for Evidence for Impact Assessment of the European Biotech Act Will Close June 11, 2025 |
Bergeson & Campbell, P.C. |
| Jun 6 2025 |
Ad Restrictions on HFSS Products in the UK to Take Effect on 5 January 2026, with Voluntary Compliance from Advertisers and Broadcasters from 1 October 2025 |
Squire Patton Boggs (US) LLP |
| Jun 6 2025 |
A Final Rule Bites the Dust, Part II: FDA Gives up on Regulating LDTs as Medical Devices |
Epstein Becker & Green, P.C. |
| Jun 6 2025 |
McDermott+ Check-Up: June 6, 2025 |
McDermott Will & Schulte LLP |
| Jun 6 2025 |
Hot Topics in Employee Benefits: A Primer for In-House Lawyers |
Epstein Becker & Green, P.C. |
| Jun 5 2025 |
No Man Is an Island: The Great Cannabis Debate |
Bradley Arant Boult Cummings LLP |
| Jun 5 2025 |
CODEX ALIMENTARIUS: Main Outcome of the 44th Committee on Methods of Analysis and Sampling (CCMAS44) |
Keller and Heckman LLP |
| Jun 5 2025 |
GLP-1 Compounded Medications Targeted by Connecticut Attorney General |
Foley & Lardner LLP |
| Jun 4 2025 |
This Week in 340B: May 27 – June 2, 2025 |
McDermott Will & Schulte LLP |
| Jun 4 2025 |
Quantum Computer Hardware: How Quantum Computers Are Implemented |
Foley & Lardner LLP |
| Jun 4 2025 |
Federal District Court Upholds Authority of HHS to Pre-Approve 340B Rebate Programs; HRSA Submits Proposed 340B Rebate Guidance |
Sheppard, Mullin, Richter & Hampton LLP |
| Jun 4 2025 |
FTC Revives Orange Book Listing Challenges |
McDermott Will & Schulte LLP |
